What type of anemia is associated with myeloma?
Anemia in myeloma is a normocytic anemia, typically presenting with fatigue, palpitations, and decreased hemoglobin levels in red blood cells, requiring prompt treatment.
Myeloma is a malignant tumor of the hematologic system, possibly associated with factors such as ionizing radiation, genetic predisposition, and exposure to chemical substances. It commonly causes persistent and progressively worsening bone pain. Infiltration of the bone marrow by myeloma cells damages normal hematopoietic tissue and impairs the body's ability to produce blood cells, leading easily to anemia. Platelet counts are usually normal or low, while white blood cell counts remain normal. This type of anemia is classified as normocytic and normochromic anemia, often causing physical weakness and chest tightness after physical activity. Under medical guidance, blood transfusion therapy can be used to effectively alleviate anemia symptoms.
Additionally, if anemia in myeloma persists, treatment under medical supervision may include erythropoietin-stimulating agents along with iron supplementation, such as ferrous sulfate oral solution or ferrous succinate oral solution. Patients are also advised to consume more iron-rich foods, such as animal organs and lean meats.